Abstract
Modification of A ring of 10-deacetylbaccatin III to get novel rearranged taxoids is described. The modification is achieved via manoeuvering of the C-11 double bond of 10-deacetylbaccatin III.
Keywords: 10-deacetylbaccatin III, rearranged taxoids, Taxus baccata var, Wallichiana, m-chloroperbenzoic acid (m-CPBA)
Letters in Organic Chemistry
Title: Modification of Taxane A Ring via Manoeuvering of the C-11 Double Bond of 10-Deacetylbaccatin III to Get Novel Rearranged Taxoids
Volume: 5 Issue: 8
Author(s): Vaishali Chakraborty and Manobjyoti Bordoloi
Affiliation:
Keywords: 10-deacetylbaccatin III, rearranged taxoids, Taxus baccata var, Wallichiana, m-chloroperbenzoic acid (m-CPBA)
Abstract: Modification of A ring of 10-deacetylbaccatin III to get novel rearranged taxoids is described. The modification is achieved via manoeuvering of the C-11 double bond of 10-deacetylbaccatin III.
Export Options
About this article
Cite this article as:
Chakraborty Vaishali and Bordoloi Manobjyoti, Modification of Taxane A Ring via Manoeuvering of the C-11 Double Bond of 10-Deacetylbaccatin III to Get Novel Rearranged Taxoids, Letters in Organic Chemistry 2008; 5 (8) . https://dx.doi.org/10.2174/157017808786857543
DOI https://dx.doi.org/10.2174/157017808786857543 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pregnane X Receptor and its Potential Role in Drug Resistance in Cancer Treatment
Recent Patents on Anti-Cancer Drug Discovery Isolation of Bioactive Natural Products from Myxomycetes
Medicinal Chemistry Bone Marrow Mesenchymal Stem Cells: Agents of Immunomodulation and Neuroprotection
Current Stem Cell Research & Therapy Defective HIF Signaling Pathway and Brain Response to Hypoxia in Neurodegenerative Diseases: Not an “Iffy” Question!
Current Pharmaceutical Design Oleacein. Translation from Mediterranean Diet to Potential Antiatherosclerotic Drug
Current Pharmaceutical Design BMPS and Liver: More Questions than Answers
Current Pharmaceutical Design Micro-RNA in Disease and Gene Therapy
Current Drug Discovery Technologies Hybrid Organic-Inorganic Scaffolding Biomaterials for Regenerative Therapies
Current Organic Chemistry Radiotracers in Oncology
Current Radiopharmaceuticals PARP Inhibitor Drugs in the Treatment of Breast, Ovarian, Prostate and Pancreatic Cancers: An Update of Clinical Trials
Current Drug Targets The BCL2-Family of Protein Ligands as Cancer Drugs: The Next Generation of Therapeutics
Current Medicinal Chemistry - Anti-Cancer Agents Applications of FDG-PET/CT in Assessment of Vascular Infection and Inflammation
Current Molecular Imaging (Discontinued) Gut-liver Axis and Microbiota in NAFLD: Insight Pathophysiology for Novel Therapeutic Target
Current Pharmaceutical Design Xanthones from Mangosteen Extracts as Natural Chemopreventive Agents: Potential Anticancer Drugs
Current Molecular Medicine Induction of Apoptosis by Nano-Synthesized Complexes of H2L and its Cu(II) Complex in Human Hepatocellular Carcinoma Cells
Anti-Cancer Agents in Medicinal Chemistry Heterocyclic Drug-polymer Conjugates for Cancer Targeted Drug Delivery
Anti-Cancer Agents in Medicinal Chemistry Synthesis and In-Vitro Antitumor Activity of Selected 7-Fluoro-6-(4-methyl-1-piperazinyl)-2-(thiosubstituted)-4(3H)-quinazolinones
Letters in Organic Chemistry α-Lipoic Acid Supplementation: A Tool for Obesity Therapy?
Current Pharmaceutical Design Multicolor Bioluminescence Obtained Using Firefly Luciferin
Current Topics in Medicinal Chemistry DLEU2: A Meaningful Long Noncoding RNA in Oncogenesis
Current Pharmaceutical Design